Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 22 citing articles:

Metabolic reprogramming and its clinical implication for liver cancer
Flora Yang, Leena Hilakivi‐Clarke, Aurpita Shaha, et al.
Hepatology (2023) Vol. 78, Iss. 5, pp. 1602-1624
Open Access | Times Cited: 61
Exploring the mystery of tumor metabolism: Warburg effect and mitochondrial metabolism fighting side by side
Yongxin Yu, Yulang Jiang, Christian Glandorff, et al.
Cellular Signalling (2024) Vol. 120, pp. 111239-111239
Closed Access | Times Cited: 13
Reprogramming of glucose metabolism: The hallmark of malignant transformation and target for advanced diagnostics and treatments
Qing Tang, Siqi Wu, Baiming Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117257-117257
Open Access | Times Cited: 9
An appraisal of the current status of inhibition of glucose transporters as an emerging antineoplastic approach: Promising potential of new pan-GLUT inhibitors
Mithlesh Kumar Temre, Ajay Kumar, Sukh Mahendra Singh
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24
pH-Sensitive Porphyrin Metal-Organic Frameworks for Controlled Delivery of Para-Toluenesulfonamide and Photodynamic Cancer Therapy
Zhou We, Fan Feng, Jieli Zhang, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 2351-2368
Open Access
Research Progress of Warburg Effect in Hepatocellular Carcinoma
Yanguang Yang, Yuting Gao, Yajun Xiong, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 5
Open Access | Times Cited: 4
Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review
Qi Wang, Juan Liu, Ziye Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116021-116021
Open Access | Times Cited: 9
Aerobic glycolysis and tumor progression of hepatocellular carcinoma are mediated by ubiquitin of P53 K48-linked regulated by TRIM37
Yuzhen Ge, Rui Zhao, Bo Li, et al.
Experimental Cell Research (2022) Vol. 421, Iss. 2, pp. 113377-113377
Closed Access | Times Cited: 14
Anti-Glycolytic Drugs in the Treatment of Hepatocellular Carcinoma: Systemic and Locoregional Options
Milad Pourbaghi‐Masouleh, Leila Haghani, Ken Zhao, et al.
Current Oncology (2023) Vol. 30, Iss. 7, pp. 6609-6622
Open Access | Times Cited: 6
Autophagy inhibition potentiates energy restriction‐induced cell death in hepatocellular carcinoma cells
Sara M. Elgendy, Dana M. Zaher, Nadin H. Sarg, et al.
IUBMB Life (2024) Vol. 76, Iss. 8, pp. 577-588
Closed Access | Times Cited: 1
Targeting Hepatocellular Carcinoma Growth and Metabolism: A Synergistic Approach with Para-Toluenesulfonamide and Radiofrequency Ablation
Liu Na, Jianzeng Zhang, Jiaojiao Wu, et al.
iLiver (2024) Vol. 3, Iss. 3, pp. 100111-100111
Open Access | Times Cited: 1
Pralatrexate represses the resistance of HCC cells to molecular targeted agents via the miRNA-34a/Notch pathway
Jin Yang, Qiming Liu, Baisheng Sun, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Hypermethylation of the Promoter Region of miR-23 Enhances the Metastasis and Proliferation of Multiple Myeloma Cells via the Aberrant Expression of uPA
Qijie Ran, Dehong Xu, Qi Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
miR-140-3p enhances the sensitivity of LUAD cells to antitumor agents by targeting the ADAM10/Notch pathway
Hao Meng, Bo Li, Wei Xu, et al.
Journal of Cancer (2022) Vol. 13, Iss. 15, pp. 3660-3673
Open Access | Times Cited: 6
A Single Nucleotide Mixture Enhances the Antitumor Activity of Molecular-Targeted Drugs Against Hepatocellular Carcinoma
Da Mao, Meihong Xu, Qiyu Jiang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 5
Glucose transporters: Important regulators of endometrial cancer therapy sensitivity
Xing Zhang, Jiajing Lu, Ayitila Abudukeyoumu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Small molecule inhibitors for cancer metabolism: promising prospects to be explored
Dan Liu, Hongping Wang, Xingxing Li, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 8051-8076
Closed Access | Times Cited: 2
Knockdown of TANK-Binding Kinase 1 Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular-Targeted Drugs
Fengxia Du, Huiwei Sun, Fang Sun, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 4
DHW-208, A Novel Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Has Anti-Hepatocellular Carcinoma Activity Through Promoting Apoptosis and Inhibiting Angiogenesis
Shu Wang, Yuting Wu, Mingyue Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Photosensitizing metal–organic framework nanoparticles combined with tumor-sensitization strategies can enhance the phototherapeutic effect upon medullary thyroid carcinoma
Yingqi Feng, Qiyu Jiang, Xue Ma, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2024) Vol. 1868, Iss. 12, pp. 130725-130725
Closed Access
Research progress in the metabolic reprogramming of hepatocellular carcinoma (Review)
Wenyue Gao, Jing Wang, Yuting Xu, et al.
Molecular Medicine Reports (2024) Vol. 30, Iss. 1
Open Access
Identification of starvation-mimetic bioactive phytocomponent from Withania somnifera using in-silico molecular modelling and flow cytometry-based analysis for the management of malaria
Deepak Pradhan, Prativa Biswasroy, Sharvari Kulkarni, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 1, pp. 528-549
Closed Access
Page 1

Scroll to top